Table 3.
Anti-elastase and anti-collagenase activity of studied EOs.
| EO | Elastase Inhibition | Collagenase Inhibition |
|---|---|---|
| IC50 (µg/mL) | IC50 (mg/mL) | |
| CAF | NI1000 | 1.46 ± 0.19 |
| CAL | 275.95 ± 13.86 | 1.54 ± 0.40 |
| CC | NI1000 | 1.34 ± 0.09 |
| CL | 89.22 ± 23.72 | 0.17 ± 0.01 |
| MC | NI1000 | 0.62 ± 0.04 |
| PA | NI1000 | 0.33 ± 0.02 |
| PC | 354.65 ± 21.43 | 0.37 ± 0.02 |
| PS | 233.47 ± 21.45 | 0.77 ± 0.17 |
| SC | 767.2 ± 27.99 | 0.84 ± 0.13 |
| SS | 459.2 ± 21.24 | 0.18 ± 0.04 |
| Positive control | ||
| Ursolic acid | 10.10 ± 15.27 | - |
| 1,1 Phenanthroline | - | 4.20 × 10−3 ± 0.00 |
CAL: Citrus aurantium leaf, CAF: Citrus aurantium fruit (peel), CC: Cinnamomum camphora; CL: Curcuma longa, MC: Morinda citrifolia, PA: Plectranthus amboinicus, PC: Petroselinum crispum; PS: Pittosporum senacia; SC: Syzygium coriaceum; SS: Syzygium samarangense; IC50: half-maximal inhibitory concentration.